Breaking News Instant updates and real-time market news.

BLRX

BioLineRx

$0.89

0.0726 (8.90%)

09:05
05/17/18
05/17
09:05
05/17/18
09:05

BioLineRx reports Phase 2 results on BL-8040 for stem cell mobilization

BioLineRx announced "positive" results from a Phase 2 clinical trial assessing BL-8040 as a single agent for hematopoietic stem cell mobilization in an allogeneic transplantation setting. Mobilization of hematopoietic stem and progenitor cells for the purpose of donor transplantation after high-dose chemotherapy is currently performed using a 4-5 day treatment cycle with G-CSF and a 1-2 day apheresis procedure. Single-agent treatment with BL-8040, a novel, high-affinity CXCR4 antagonist with rapid HSPC mobilizing kinetics, showed similar efficacy in only one administration. In addition, BL-8040 showed non-inferiority in recipient engraftment, with all transplanted recipients successfully engrafting with BL-8040-mobilized grafts. Of the 21 evaluable donors that have been enrolled in the study to date, 11 out of 13 donors, 85%, treated at the 1 mg/kg dose and 8/8 donors, 100%, treated at the 1.25 mg/kg dose of BL-8040 reached the primary goal of greater than or equal to2x106 CD34 cells/kg of recipient weight in up to 2 leukapheresis sessions. BL-8040 was safe and well tolerated. 13 transplanted recipients have reached the secondary endpoint of 100 days post-transplant. Results of the lead-in period from the Phase 3 trial are expected in the next few months.

  • 22

    May

BLRX BioLineRx
$0.89

0.0726 (8.90%)

05/18/17
MAXM
05/18/17
UPGRADE
Target $3
MAXM
Buy
BioLineRx upgraded to Buy from Hold at Maxim
Maxim analyst Jason Kolbert upgraded BioLineRx to Buy from Hold as the company is now closer to being a pivotal company after announcing it will initiate a Phase 3 program for BL-8040 in stem cell mobilization later this year. Kolbert, who believes the stock can start to outperform in 2017, raised his price target on BioLineRx to $3 from $1.
05/18/17
05/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Progressive (PGR) upgraded to Hold from Sell at Deutsche Bank with analyst Joshua Shanker saying his concerns over the company's margins "are not longer apt" and that sees no catalyst to the downside. 2. Shake Shack (SHAK) upgraded to Outperform from Neutral at Wedbush with analyst Nick Setyan saying the valuation at current share levels is attractive given Shake Shack's "industry-leading growth trajectory. 3. CarMax (KMX) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying the company's CAF credit losses will probably rise less in 2017 than in 2016, reducing "the risk of a credit-driven blowout." 4. Bank of Montreal (BMO) upgraded to Buy from Neutral at Citi with analyst Ian Sealey citing the recent pullback in the shares of Canadian banks as he sees "strong" book value and dividend growth over the longer term. 5. BioLineRx (BLRX) upgraded to Buy from Hold at Maxim with analyst Jason Kolbert saying the company is now closer to being a pivotal company after announcing it will initiate a Phase 3 program for BL-8040 in stem cell mobilization later this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/17
OPCO
08/03/17
INITIATION
Target $3
OPCO
Outperform
BioLineRx initiated with an Outperform at Oppenheimer
Oppenheimer analyst Mark Breidenbach initiated BioLineRx with a $3 price target saying its lead asset, BL-8040, could could unseat Sanofi's plerixafor as the preferred agent to combine with G-CSF for mobilizing stem cells in autologous hematopoietic stem cell transplants and said its Phase 3 GENESIS trial in the second half has a high probability of success.
03/06/18
HCWC
03/06/18
NO CHANGE
HCWC
H.C. Wainwright sees several second half data catalysts for BioLineRx
H.C. Wainwright analyst Joseph Pantginis noted that BioLineRx's Q4 and FY17 financial results missed the firm's estimates slightly, but he was optimistic about the company's second half data catalysts -- including topline results from COMBAT, lead-in stage results for the Phase 3 GENESIS study, partial results from Phase 1b/2 studies for BL-8040 in combination with Tecentriq in gastric cancer, NSCLC, and AML, as well as data from multiple other studies. Pantginis reiterated a Buy rating and has a $4 price target on BioLineRx shares.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$85.74

-1.63 (-1.87%)

09:05
05/23/18
05/23
09:05
05/23/18
09:05
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's outgoing CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

LOW

Lowe's

$85.74

-1.63 (-1.87%)

, JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

09:05
05/23/18
05/23
09:05
05/23/18
09:05
Hot Stocks
Outgoing Lowe's CEO says Ellison the 'ideal' person to serve as next CEO »

Retiring Chairman and CEO…

LOW

Lowe's

$85.74

-1.63 (-1.87%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Technical Analysis
Technical Take: SPDR S&P 500 ETF falls heading toward the open »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNS

Colony NorthStar

$5.78

-0.09 (-1.53%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Hot Stocks
Colony NorthStar announces additional $300M stock repurchase program »

Colony NorthStar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

RMTI

Rockwell Medical

$5.94

-0.06 (-1.00%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Hot Stocks
Rockwell Medical board removes CFO after 'unauthorized' filing »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$50.87

-1.4 (-2.68%)

, CAA

CalAtlantic

$0.00

(0.00%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Recommendations
Lennar, CalAtlantic analyst commentary  »

Lennar price target…

LEN

Lennar

$50.87

-1.4 (-2.68%)

CAA

CalAtlantic

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

H

Hyatt

$80.47

-0.725 (-0.89%)

09:03
05/23/18
05/23
09:03
05/23/18
09:03
Hot Stocks
Hyatt opens Regency Shenzhen Airport Hotel »

Hyatt announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$61.40

-0.71 (-1.14%)

09:02
05/23/18
05/23
09:02
05/23/18
09:02
Hot Stocks
Abbott receives FDA approval for XIENCE Sierra »

Abbott announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil Circuit

$28.27

0.11 (0.39%)

09:02
05/23/18
05/23
09:02
05/23/18
09:02
Hot Stocks
Jabil expands in Israel with opening of Optics Technology Innovation Center »

Green Point, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$49.52

-0.47 (-0.94%)

, CBSH

Commerce Bancshares

$65.50

0.11 (0.17%)

09:01
05/23/18
05/23
09:01
05/23/18
09:01
Hot Stocks
Commerce Bancshares picks SS&C for CECL transition »

SS&C Technologies…

SSNC

SS&C

$49.52

-0.47 (-0.94%)

CBSH

Commerce Bancshares

$65.50

0.11 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

AVID

Avid Technology

$5.00

-0.02 (-0.40%)

09:01
05/23/18
05/23
09:01
05/23/18
09:01
Hot Stocks
Avid Technology selected by Seneca College for media facilities upgrade »

Avid announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$80.43

-0.48 (-0.59%)

09:00
05/23/18
05/23
09:00
05/23/18
09:00
Recommendations
VF Corp. analyst commentary  »

VF Corp. removed as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$6.91

-0.05 (-0.72%)

08:59
05/23/18
05/23
08:59
05/23/18
08:59
Syndicate
Pfenex 6.8M share Spot Secondary priced at $5.50 »

Barclays and William…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

TIF

Tiffany

$102.26

-0.96 (-0.93%)

08:58
05/23/18
05/23
08:58
05/23/18
08:58
Hot Stocks
Tiffany says engagement category is at the core of the company »

Says paper flower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

IGT

International Game

$28.47

-1.28 (-4.30%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
International Game 18M share Secondary priced at $28.25 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 23

    May

TSC

TriState Capital

$27.05

0.2 (0.74%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
TriState Capital 2.2M share Spot Secondary priced at $25.90 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    May

TJX

TJX

$87.50

2.84 (3.35%)

, M

Macy's

$33.12

-1.48 (-4.28%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Recommendations
TJX, Macy's, Kohl's, J.C. Penney analyst commentary  »

TJX results 'more…

TJX

TJX

$87.50

2.84 (3.35%)

M

Macy's

$33.12

-1.48 (-4.28%)

KSS

Kohl's

$60.60

-4.87 (-7.44%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MU

Micron

$58.95

3.47 (6.25%)

, BAC

Bank of America

$30.89

0.34 (1.11%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Options
Notable open interest changes for May 23rd »

Tuesday's total…

MU

Micron

$58.95

3.47 (6.25%)

BAC

Bank of America

$30.89

0.34 (1.11%)

NXPI

NXP Semiconductors

$115.55

0.84 (0.73%)

CHK

Chesapeake

$4.54

-0.065 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

, EOG

EOG Resources

$123.76

-3.69 (-2.90%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
UBS to hold a conference »

Global Oil & Gas…

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

EOG

EOG Resources

$123.76

-3.69 (-2.90%)

HP

Helmerich & Payne

$70.74

-1.83 (-2.52%)

RRC

Range Resources

$15.45

-0.63 (-3.92%)

SWN

Southwestern Energy

$4.66

-0.07 (-1.48%)

TDW

Tidewater

$31.48

0.1 (0.32%)

NE

Noble Corp.

$5.86

-0.15 (-2.50%)

HES

Hess Corp.

$63.83

-1.42 (-2.18%)

TUSK

Mammoth Energy

$34.59

-1.27 (-3.54%)

DVN

Devon Energy

$41.82

-0.51 (-1.20%)

ICD

Independence Contract Drilling

$4.89

-0.25 (-4.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

  • 25

    Jun

  • 27

    Jun

  • 20

    Jul

  • 19

    Aug

TMO

Thermo Fisher

$217.88

1.2 (0.55%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
Thermo Fisher to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

CY

Cypress Semiconductor

$16.31

0.2 (1.24%)

08:54
05/23/18
05/23
08:54
05/23/18
08:54
Initiation
Cypress Semiconductor initiated  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 13

    Jun

  • 14

    Jun

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

08:52
05/23/18
05/23
08:52
05/23/18
08:52
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$21.92

0.5 (2.33%)

08:51
05/23/18
05/23
08:51
05/23/18
08:51
Recommendations
Marvell analyst commentary  »

Marvell April quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IDTI

Integrated Device

$32.49

0.41 (1.28%)

08:50
05/23/18
05/23
08:50
05/23/18
08:50
Initiation
Integrated Device initiated  »

Integrated Device…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TIF

Tiffany

$102.26

-0.96 (-0.93%)

08:49
05/23/18
05/23
08:49
05/23/18
08:49
Hot Stocks
Tiffany says it had success in Japan, Europe »

Says sales rose 18% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.